These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
515 related articles for article (PubMed ID: 20127709)
21. Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes. Moriyama H; Yonehara S Immunol Lett; 2007 Mar; 109(1):36-46. PubMed ID: 17275920 [TBL] [Abstract][Full Text] [Related]
22. Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Zhang L; Fang B Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937 [TBL] [Abstract][Full Text] [Related]
23. Overexpression of cFLIPs inhibits oxaliplatin-mediated apoptosis through enhanced XIAP stability and Akt activation in human renal cancer cells. Kim S; Lee TJ; Park JW; Kwon TK J Cell Biochem; 2008 Nov; 105(4):971-9. PubMed ID: 18767116 [TBL] [Abstract][Full Text] [Related]
24. Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4. Kurbanov BM; Fecker LF; Geilen CC; Sterry W; Eberle J Oncogene; 2007 May; 26(23):3364-77. PubMed ID: 17160022 [TBL] [Abstract][Full Text] [Related]
25. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance. Ng CP; Zisman A; Bonavida B Prostate; 2002 Dec; 53(4):286-99. PubMed ID: 12430140 [TBL] [Abstract][Full Text] [Related]
26. NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL). Pawlowski JE; Nesterov A; Scheinman RI; Johnson TR; Kraft AS Anticancer Res; 2000; 20(6B):4243-55. PubMed ID: 11205254 [TBL] [Abstract][Full Text] [Related]
27. Over-expression of Reticulon 3 (RTN3) enhances TRAIL-mediated apoptosis via up-regulation of death receptor 5 (DR5) and down-regulation of c-FLIP. Lee JT; Lee TJ; Kim CH; Kim NS; Kwon TK Cancer Lett; 2009 Jul; 279(2):185-92. PubMed ID: 19250737 [TBL] [Abstract][Full Text] [Related]
28. Role of caspases in CD95L- and TRAIL-induced non-apoptotic signalling in pancreatic tumour cells. Siegmund D; Klose S; Zhou D; Baumann B; Röder C; Kalthoff H; Wajant H; Trauzold A Cell Signal; 2007 Jun; 19(6):1172-84. PubMed ID: 17291719 [TBL] [Abstract][Full Text] [Related]
29. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5. Mitsiades N; Poulaki V; Mitsiades C; Tsokos M Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151 [TBL] [Abstract][Full Text] [Related]
30. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis. Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154 [TBL] [Abstract][Full Text] [Related]
31. Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis. Wang P; Song JH; Song DK; Zhang J; Hao C Cell Signal; 2006 Sep; 18(9):1528-35. PubMed ID: 16442262 [TBL] [Abstract][Full Text] [Related]
32. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells. Shi RX; Ong CN; Shen HM Cancer Res; 2005 Sep; 65(17):7815-23. PubMed ID: 16140950 [TBL] [Abstract][Full Text] [Related]
33. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB. Ou D; Wang X; Metzger DL; Robbins M; Huang J; Jobin C; Chantler JK; James RF; Pozzilli P; Tingle AJ Hum Immunol; 2005 Jul; 66(7):799-809. PubMed ID: 16112027 [TBL] [Abstract][Full Text] [Related]
34. Selective Akt inactivation and tumor necrosis actor-related apoptosis-inducing ligand sensitization of renal cancer cells by low concentrations of paclitaxel. Asakuma J; Sumitomo M; Asano T; Asano T; Hayakawa M Cancer Res; 2003 Mar; 63(6):1365-70. PubMed ID: 12649200 [TBL] [Abstract][Full Text] [Related]
35. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Chawla-Sarkar M; Bae SI; Reu FJ; Jacobs BS; Lindner DJ; Borden EC Cell Death Differ; 2004 Aug; 11(8):915-23. PubMed ID: 15118763 [TBL] [Abstract][Full Text] [Related]
36. The sesquiterpene lactone eupatolide sensitizes breast cancer cells to TRAIL through down-regulation of c-FLIP expression. Lee J; Hwangbo C; Lee JJ; Seo J; Lee JH Oncol Rep; 2010 Jan; 23(1):229-37. PubMed ID: 19956887 [TBL] [Abstract][Full Text] [Related]
37. Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia. MacFarlane M; Harper N; Snowden RT; Dyer MJ; Barnett GA; Pringle JH; Cohen GM Oncogene; 2002 Oct; 21(44):6809-18. PubMed ID: 12360407 [TBL] [Abstract][Full Text] [Related]
38. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation. Shigeno M; Nakao K; Ichikawa T; Suzuki K; Kawakami A; Abiru S; Miyazoe S; Nakagawa Y; Ishikawa H; Hamasaki K; Nakata K; Ishii N; Eguchi K Oncogene; 2003 Mar; 22(11):1653-62. PubMed ID: 12642868 [TBL] [Abstract][Full Text] [Related]
39. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5. Choi SY; Kim MJ; Chung HY; Lee SJ; Jang YJ Oncol Rep; 2007 Jan; 17(1):175-84. PubMed ID: 17143496 [TBL] [Abstract][Full Text] [Related]
40. Defining characteristics of Types I and II apoptotic cells in response to TRAIL. Ozören N; El-Deiry WS Neoplasia; 2002; 4(6):551-7. PubMed ID: 12407450 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]